Methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia is associated with high morbidity and mortality. Usually, antistaphylococcal penicillins (ASPs) have been considered the agents of choice for the treatment of MSSA bacteremia.
Optimal medication therapy for MSSA infections is unclear. Current standard of care consists of nafcillin, oxacillin and cefazolin. Ceftriaxone has advantage as a once-daily outpatient regimen. (1)
Current evidence suggests there is no difference in efficacy between ceftriaxone and ASPs for MSSA infection, with a lower risk of toxicity with ceftriaxone. Ceftriaxone is a good option for definitive therapy of MSSA infection. (1)
Real time patient medications:
Diagnosis: Back pain, sepsis due to MSSA bacteremia and Lumbar spine abscess.
Preventing strategies for MSSA infection:
Wash hands; wear gloves; keep wounds covered; keep personal items like towels, sheets and razors separate
References:
1. Yetmar ZA, Razi S, Nayfeh T, Gerberi DJ, Mahmood M, Abu Saleh OM. Ceftriaxone versus antistaphylococcal antibiotics for definitive treatment of methicillin-susceptible Staphylococcus aureus infections: a systematic review and meta-analysis. Int J Antimicrob Agents. 2022 Jan;59(1):106486. doi: 10.1016/j.ijantimicag.2021.106486. Epub 2021 Nov 26
Comments
Post a Comment